Guardant Health (FRA:5GH) Short-Term Capital Lease Obligation : €25.7 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Guardant Health Short-Term Capital Lease Obligation?

Guardant Health's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €25.7 Mil.

Guardant Health's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€24.7 Mil) to Dec. 2023 (€25.6 Mil) and increased from Dec. 2023 (€25.6 Mil) to Mar. 2024 (€25.7 Mil).

Guardant Health's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€11.4 Mil) to Dec. 2022 (€20.7 Mil) and increased from Dec. 2022 (€20.7 Mil) to Dec. 2023 (€25.6 Mil).

Guardant Health Short-Term Capital Lease Obligation Historical Data

The historical data trend for Guardant Health's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Short-Term Capital Lease Obligation Chart

Guardant Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

6.43

5.45

11.38

20.65

25.63

Guardant Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															22.06	22.81	24.70	25.63	25.72

Guardant Health Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Guardant Health Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Guardant Health's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardant Health (FRA:5GH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (FRA:5GH) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

GH:USA

Address

3100 Hanover Street, Palo Alto, CA, USA, 94304

Website

https://www.guardanthealth.com

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health (FRA:5GH) Headlines

No Headlines